Ceptur Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Ceptur Therapeutics General Information

Description

Developer of U1 adaptor technology designed to facilitate the creation of treatment. The company's technology overcomes the limitations of gene silencing technologies and offers cancer treatment, enabling doctors to treat patients with various types of cancers.

Contact Information

Website
www.cepturtx.com
Formerly Known As
Silagene
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1 Ilene Court, Building 8
  • Suite 9
  • Hillsborough, NJ 08844
  • United States
+1 (908)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 1 Ilene Court, Building 8
  • Suite 9
  • Hillsborough, NJ 08844
  • United States
+1 (908)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ceptur Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 12-Nov-2025 Completed Out of Business
3. Later Stage VC (Series A) 19-Jan-2022 Completed Generating Revenue
2. Seed Round 13-Aug-2020 $6.2M $6.2M Completed Clinical Trials - Phase 1
1. Grant 01-Jan-2010 $189K Completed Startup
To view Ceptur Therapeutics’s complete valuation and funding history, request access »

Ceptur Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Ceptur Therapeutics’s complete cap table history, request access »

Ceptur Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of U1 adaptor technology designed to facilitate the creation of treatment. The company's technology overcomes
Drug Discovery
Hillsborough, NJ
6 As of 2023

Brisbane, CA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ceptur Therapeutics Competitors (3)

One of Ceptur Therapeutics’s 3 competitors is ReviR Therapeutics, a Venture Capital-Backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ReviR Therapeutics Venture Capital-Backed Brisbane, CA
Arrakis Therapeutics Venture Capital-Backed Waltham, MA
GeneCentric Venture Capital-Backed NC
You’re viewing 3 of 3 competitors. Get the full list »

Ceptur Therapeutics Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Ceptur Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022197356-A1 Compositions and methods for kras gene silencing Inactive 19-Mar-2021
AU-2020248392-A1 Compositions and methods for treating neurodegenerative disorders Inactive 26-Mar-2019
CA-3134683-A1 Compositions and methods for treating neurodegenerative disorders Pending 26-Mar-2019
EP-3946375-A1 Compositions and methods for treating neurodegenerative disorders Inactive 26-Mar-2019
US-20220372488-A1 Compositions and methods for treating neurodegenerative disorders Inactive 26-Mar-2019 A61K31/7088
To view Ceptur Therapeutics’s complete patent history, request access »

Ceptur Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Ceptur Therapeutics FAQs

  • When was Ceptur Therapeutics founded?

    Ceptur Therapeutics was founded in 2008.

  • Where is Ceptur Therapeutics headquartered?

    Ceptur Therapeutics is headquartered in Hillsborough, NJ.

  • What is the size of Ceptur Therapeutics?

    Ceptur Therapeutics has 6 total employees.

  • What industry is Ceptur Therapeutics in?

    Ceptur Therapeutics’s primary industry is Drug Discovery.

  • Is Ceptur Therapeutics a private or public company?

    Ceptur Therapeutics is a Private company.

  • What is Ceptur Therapeutics’s current revenue?

    The current revenue for Ceptur Therapeutics is .

  • How much funding has Ceptur Therapeutics raised over time?

    Ceptur Therapeutics has raised $81.2M.

  • Who are Ceptur Therapeutics’s competitors?

    ReviR Therapeutics, Arrakis Therapeutics, and GeneCentric are competitors of Ceptur Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process